Red Nano QBD · Presentation
Nanomedicine R&D
Red Nano QBD
Evidence-aware formulation and quality-by-design workspace for nanoparticle development.
Illustrative workflow
Comparing two formulations
Which formulation change is worth investigating next?
Compare two composition records and their process settings. Relate the difference to experimental design and the available size, dispersity and stability evidence.
Keep the measured result, the proposed explanation and the next experiment separate.
Module notes
Formulation Registry & CQA / CPP
- Formulation Registry
- Composition, process, provenance and versioned experiment records.
- CQA / CPP
- Quality attributes, process parameters, risk links and evidence.
Module notes
DoE Analytics & Characterisation
- DoE Analytics
- Design-space experiments, comparisons and reviewable calculations.
- Characterisation
- Size, PDI, zeta, morphology, release and stability evidence.
Readiness and access
Developed baseline
The named functions have a developed baseline. Check the release and qualification evidence for the version and environment you intend to use.
Evaluation builds stay with the vendor. The download centre lists software approved for licensed customers.